Joel Ho

Joel Ho has a diverse and extensive work experience in the pharmaceutical and healthcare industry. Joel is currently working as the Head of Market Development at Sapyen since 2023. Previously, they worked at Sanofi from 2017 to 2023, where they held multiple roles. Joel served as the Senior Product Manager - Launch Vaccines, responsible for leading the private market launch of Fluzone High-Dose Quadrivalent for adults aged 60+. Joel also led the strategic direction and tactical activation plan for the Sanofi Influenza Vaccines portfolio. Additionally, they worked as the RSV Market Lead JPAC Region (Global Marketing), overseeing the launch strategy for the Respiratory Syncytial Virus (RSV) Vaccine in various markets, and as the Senior Product Manager Launch Vaccines, responsible for Flublok and RSV. Before Sanofi, Joel worked at Novo Nordisk as the Marketing Manager and Senior Product Manager, where they led the brand strategy for NovoMix 30 premix insulin and the overall modern insulin portfolio. Prior to that, they worked as a Business Development Manager at Gate Healthcare, where they launched new surgical devices in Australian and US markets. Joel's early career includes roles at Pfizer, where they served as the Senior Brand Manager for Champix, leading prescription treatment for smoking cessation, and as the Senior Brand Manager / Brand Manager for the Ophthalmology portfolio, which included Xalatan and Xalacom eye-drop treatments for Glaucoma. Joel also worked as a Sales Representative for Respiratory & Cardiovascular products at Pfizer. Throughout their career, Joel has demonstrated expertise in brand strategy, market development, product management, and launching new products, in addition to sales and marketing leadership.

Joel Ho attended Deakin University from 1998 to 2000, where they obtained a B.App Science degree. No specific field of study was mentioned.